RecruitingNCT05611307

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant

Sponsor

Indiana University

Enrollment

150 participants

Start Date

Oct 11, 2022

Study Type

OBSERVATIONAL

Conditions

Survivorship Testicular Cancer Hypogonadism, Male Coronary Artery Disease Bone Marrow Transplant Complications ASCVD Lipid Disorder Cisplatin Adverse Reaction

Summary

Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Coronary artery assessment, Hormone levels for hypogonadism, and others for people with ascvd, bone marrow transplant complications, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.